{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Pueraria lobata", "Pueraria thomsonii", "Pueraria tuberosa", "Puerarin", "medicinal plants", "natural products"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32021425", "DateRevised": {"Year": "2020", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "01", "Day": "08"}], "Language": ["eng"], "ELocationID": ["10.2147/CMAR.S233567"], "Journal": {"ISSN": "1179-1322", "JournalIssue": {"Volume": "12", "PubDate": {"Year": "2020"}}, "Title": "Cancer management and research", "ISOAbbreviation": "Cancer Manag Res"}, "ArticleTitle": "Molecular Mechanisms of Anticancer Activities of Puerarin.", "Pagination": {"StartPage": "79", "EndPage": "90", "MedlinePgn": "79-90"}, "Abstract": {"AbstractText": ["Medicinal plants are a vital source of natural products (NPs) that can cure cancer through modulation of different pathways, including oxidative stress, extrinsic and intrinsic apoptosis, cell cycle, inflammation, NF-kB, PI3K/AKT/mTOR, AMPK (JNK), MEK/ERK (Raf)-MEK-ERK and autophagy. Puerarin (Pue), an important NP belonging to the isoflavone glycoside group, is derived from <i>Pueraria lobata</i> (Willd.) Ohwi, <i>Pueraria thomsonii</i> Benth, and <i>Pueraria tuberosa</i> (Willd.). This NP was approved by the Chinese Ministry of Health for the treatment of different diseases in 1993, but it was also later reported to exhibit anticancer activity. Pue causes cancer cells death through modulation of different mechanisms including oxidative stress, intrinsic and extrinsic, Survivin and XIAP, PI3K/AKT/mTOR, Ras-Raf-MEK-ERK, JNK, cell cycle, AMPK, NF-kB, inflammation and autophagy pathways. Therefore, this review compiles for the first time the studies about the anticancer mechanism of Pue and provides comprehensive information about the anticancer effects of Pue. This review may serve as a basis for future research and clinical treatment."], "CopyrightInformation": "\u00a9 2020 Ahmad et al."}, "AuthorList": [{"Identifier": ["0000-0002-3109-704X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology and Pathophysiology, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning 116044, People's Republic of China."}], "LastName": "Ahmad", "ForeName": "Bashir", "Initials": "B"}, {"Identifier": ["0000-0003-4954-0748"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "Henan Medical Key Laboratory of Translational Cerebrovascular Diseases, Zhengzhou, People's Republic of China."}], "LastName": "Khan", "ForeName": "Suliman", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "Henan Medical Key Laboratory of Translational Cerebrovascular Diseases, Zhengzhou, People's Republic of China."}], "LastName": "Liu", "ForeName": "Yang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "Henan Medical Key Laboratory of Translational Cerebrovascular Diseases, Zhengzhou, People's Republic of China."}], "LastName": "Xue", "ForeName": "Mengzhou", "Initials": "M"}, {"Identifier": ["0000-0001-5256-0083"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology of Hebei Province, College of Life Sciences, Hebei Normal University, Shijiazhuang 050024, People's Republic of China."}], "LastName": "Nabi", "ForeName": "Ghulam", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Key Laboratory of Aquatic Biodiversity and Conservation, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan 430072, People's Republic of China."}], "LastName": "Kumar", "ForeName": "Sunjeet", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory, The First Affiliated Hospital, Dalian Medical University, Dalian, Liaoning 116044, People's Republic of China."}], "LastName": "Alshwmi", "ForeName": "Mohammed", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, Liaoning 116044, People's Republic of China."}], "LastName": "Qarluq", "ForeName": "Abdul Wakeel", "Initials": "AW"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Cancer Manag Res", "NlmUniqueID": "101512700", "ISSNLinking": "1179-1322"}, "CoiStatement": "The authors declare no con\ufb02ict of interest related to this work."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Pengyu S, Ahmad B, Lijuan Z. Natural \u03b2-elemene: advances in targeting cancer through different molecular pathways. North Am J Academic Res. 2018;1(4):27."}, {"Citation": "Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, et al. Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol Adv. 2015;33(8):1582\u20131614. doi:10.1016/j.biotechadv.2015.08.001", "ArticleIdList": ["10.1016/j.biotechadv.2015.08.001", "PMC4748402", "26281720"]}, {"Citation": "Bui TT, Nguyen TH. Natural product for the treatment of alzheimer\u2019s disease. J Basic Clin Physiol Pharmacol. 2017;28(5):413\u2013423. doi:10.1515/jbcpp-2016-0147", "ArticleIdList": ["10.1515/jbcpp-2016-0147", "28708573"]}, {"Citation": "Hirsch GE, Viecili PRN, de Almeida AS, et al. Natural products with antiplatelet action. Curr Pharm Des. 2017;23(8):1228\u20131246. doi:10.2174/1381612823666161123151611", "ArticleIdList": ["10.2174/1381612823666161123151611", "27881059"]}, {"Citation": "Jahan S, Kumar D, Chaturvedi S, et al. Therapeutic targeting of NLRP3 inflammasomes by natural products and pharmaceuticals: a novel mechanistic approach for inflammatory diseases. Curr Med Chem. 2017;24(16):1645\u20131670. doi:10.2174/0929867324666170227121619", "ArticleIdList": ["10.2174/0929867324666170227121619", "28245768"]}, {"Citation": "Kohansal MH, Nourian A, Rahimi MT, Daryani A, Spotin A, Ahmadpour E. Natural products applied against hydatid cyst protoscolices: a review of past to present. Acta Trop. 2017;176:385\u2013394. doi:10.1016/j.actatropica.2017.09.013", "ArticleIdList": ["10.1016/j.actatropica.2017.09.013", "28935552"]}, {"Citation": "Parvez MK. Natural or plant products for the treatment of neurological disorders: current knowledge. Curr Drug Metab. 2018;19(5):424\u2013428. doi:10.2174/1389200218666170710190249", "ArticleIdList": ["10.2174/1389200218666170710190249", "28699506"]}, {"Citation": "Rios JL, Francini F, Schinella GR. Natural products for the treatment of type 2 diabetes mellitus. Planta Med. 2015;81(12\u201313):975\u2013994. doi:10.1055/s-0035-1546131", "ArticleIdList": ["10.1055/s-0035-1546131", "26132858"]}, {"Citation": "Dixon RA, Sumner LW. Legume natural products: understanding and manipulating complex pathways for human and animal health. Plant Physiol. 2003;131(3):878\u2013885. doi:10.1104/pp.102.017319", "ArticleIdList": ["10.1104/pp.102.017319", "PMC1540287", "12644640"]}, {"Citation": "Prasad S, Phromnoi K, Yadav VR, Chaturvedi MM, Aggarwal BB. Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer. Planta Med. 2010;76(11):1044\u20131063. doi:10.1055/s-0030-1250111", "ArticleIdList": ["10.1055/s-0030-1250111", "20635307"]}, {"Citation": "Zhang Z, Lam TN, Zuo Z. Radix puerariae: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol. 2013;53(8):787\u2013811. doi:10.1002/jcph.96", "ArticleIdList": ["10.1002/jcph.96", "23677886"]}, {"Citation": "Cherdshewasart W, Subtang S, Dahlan W. Major isoflavonoid contents of the phytoestrogen rich-herb pueraria mirifica in comparison with pueraria lobata. J Pharm Biomed Anal. 2007;43(2):428\u2013434. doi:10.1016/j.jpba.2006.07.013", "ArticleIdList": ["10.1016/j.jpba.2006.07.013", "16930918"]}, {"Citation": "Maji AK, Pandit S, Banerji P, Banerjee D. Pueraria tuberosa: a review on its phytochemical and therapeutic potential. Nat Prod Res. 2014;28(23):2111\u20132127. doi:10.1080/14786419.2014.928291", "ArticleIdList": ["10.1080/14786419.2014.928291", "24980468"]}, {"Citation": "Maji AK, Maity N, Banerji P, Banerjee D. A validated RP-HPLC-UV method for quantitative determination of puerarin in pueraria tuberosa DC tuber extract. Pharm Methods. 2012;3(2):79\u201383. doi:10.4103/2229-4708.103879", "ArticleIdList": ["10.4103/2229-4708.103879", "PMC3658094", "23781483"]}, {"Citation": "Chauhan SK, Singh B, Agrawal S. Determination of puerarin from pueraria tuberosa dc by HPLC. Anc Sci Life. 2004;23(3):22\u201325.", "ArticleIdList": ["PMC3330973", "22557128"]}, {"Citation": "Wong KH, Li GQ, Li KM, Razmovski-Naumovski V, Chan K. Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases. J Ethnopharmacol. 2011;134(3):584\u2013607. doi:10.1016/j.jep.2011.02.001", "ArticleIdList": ["10.1016/j.jep.2011.02.001", "21315814"]}, {"Citation": "Chen R, Xue J, Xie M. Puerarin prevents isoprenaline-induced myocardial fibrosis in mice by reduction of myocardial TGF-beta1 expression. J Nutr Biochem. 2012;23(9):1080\u20131085. doi:10.1016/j.jnutbio.2011.05.015", "ArticleIdList": ["10.1016/j.jnutbio.2011.05.015", "22079205"]}, {"Citation": "Wei SY, Chen Y, Xu XY. Progress on the pharmacological research of puerarin: a review. Chin J Nat Med. 2014;12(6):407\u2013414. doi:10.1016/S1875-5364(14)60064-9", "ArticleIdList": ["10.1016/S1875-5364(14)60064-9", "24969520"]}, {"Citation": "Wang J, Yang ZR, Guo XF, et al. Synergistic effects of puerarin combined with 5- fluorouracil on esophageal cancer. Mol Med Rep. 2014;10(5):2535\u20132541. doi:10.3892/mmr.2014.2539", "ArticleIdList": ["10.3892/mmr.2014.2539", "25189132"]}, {"Citation": "Kitano H. Systems biology: a brief overview. Science. 2002;295(5560):1662\u20131664. doi:10.1126/science.1069492", "ArticleIdList": ["10.1126/science.1069492", "11872829"]}, {"Citation": "Luo CF, Yuan M, Chen MS, Liu SM, Ji H. Metabolites of puerarin identified by liquid chromatography tandem mass spectrometry: similar metabolic profiles in liver and intestine of rats. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878(3\u20134):363\u2013370. doi:10.1016/j.jchromb.2009.12.002", "ArticleIdList": ["10.1016/j.jchromb.2009.12.002", "20006564"]}, {"Citation": "Wong R, Rabie B. Effect of puerarin on bone formation. Osteoarthritis Cartilage. 2007;15(8):894\u2013899. doi:10.1016/j.joca.2007.02.009", "ArticleIdList": ["10.1016/j.joca.2007.02.009", "17379543"]}, {"Citation": "Pan ZY, Bao ZS, Wu ZM, et al. The myocardial protective effects of puerarin on STZinduced diabetic rats. Fen Zi Xi Bao Sheng Wu Xue Bao. 2009;42(2):137\u2013144.", "ArticleIdList": ["19537197"]}, {"Citation": "Yao XJ, Yin JA, Xia YF, et al. Puerarin exerts antipyretic effect on lipopolysaccharide induced fever in rats involving inhibition of pyrogen production from macrophages. J Ethnopharmacol. 2012;141(1):322\u2013330. doi:10.1016/j.jep.2012.02.038", "ArticleIdList": ["10.1016/j.jep.2012.02.038", "22401764"]}, {"Citation": "Lin F, Xie B, Cai F, Wu G. Protective effect of puerarin on beta-amyloid-induced neurotoxicity in rat hippocampal neurons. Arzneimittelforschung. 2012;62(4):187\u2013193. doi:10.1055/s-0031-1299763", "ArticleIdList": ["10.1055/s-0031-1299763", "22278629"]}, {"Citation": "Zhao M, Du YQ, Yuan L, Wang NN. Protective effect of puerarin on acute alcoholic liver injury. Am J Chin Med. 2010;38(2):241\u2013249. doi:10.1142/S0192415X10007816", "ArticleIdList": ["10.1142/S0192415X10007816", "20387222"]}, {"Citation": "Penetar DM, Toto LH, Farmer SL, et al. The isoflavone puerarin reduces alcohol intake in heavy drinkers: a pilot study. Drug Alcohol Depend. 2012;126(1\u20132):251\u2013256. doi:10.1016/j.drugalcdep.2012.04.012", "ArticleIdList": ["10.1016/j.drugalcdep.2012.04.012", "PMC3430804", "22578529"]}, {"Citation": "Wang Q, Wu T, Chen X, et al. Puerarin injection for unstable angina pectoris. Cochrane Database Syst Rev. 2006;3:Cd004196.", "ArticleIdList": ["16856037"]}, {"Citation": "Tan Y, Liu M, Wu B. Puerarin for acute ischaemic stroke. Cochrane Database Syst Rev. 2008;1:Cd004955.", "ArticleIdList": ["18254067"]}, {"Citation": "le Sage C, Agami R. Immense promises for tiny molecules: uncovering miRNA functions. Cell Cycle. 2006;5(13):1415\u20131421. doi:10.4161/cc.5.13.2890", "ArticleIdList": ["10.4161/cc.5.13.2890", "16775415"]}, {"Citation": "Li Y, Pan WS, Chen SL, Xu HX, Yang DJ, Chan AS. Pharmacokinetic, tissue distribution, and excretion of puerarin and puerarin-phospholipid complex in rats. Drug Dev Ind Pharm. 2006;32(4):413\u2013422. doi:10.1080/03639040600559123", "ArticleIdList": ["10.1080/03639040600559123", "16638679"]}, {"Citation": "Sfakianos J, Coward L, Kirk M, Barnes S. Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J Nutr. 1997;127(7):1260\u20131268. doi:10.1093/jn/127.7.1260", "ArticleIdList": ["10.1093/jn/127.7.1260", "9202077"]}, {"Citation": "Luo C, Yuan M, Chen M, Liu S, Zhu L, Liu X. Determination of puerarin in rat plasma by HPLC with fluorescence detection and its application to pharmacokinetic studies. Lat Am J Pharm. 2009;28:351\u2013357."}, {"Citation": "Luo C, Yuan M, Chen M, Xiong W, Tian J. Study on the correlation between excretion of puerarin and administration routes in rats. Strait Pharm J. 2009;21(4):41\u201344."}, {"Citation": "Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8(7):579\u2013591. doi:10.1038/nrd2803", "ArticleIdList": ["10.1038/nrd2803", "19478820"]}, {"Citation": "Hong YH, Uddin MH, Jo U, et al. ROS accumulation by PEITC selectively kills ovarian cancer cells via UPR-mediated apoptosis. Front Oncol. 2015;5:167. doi:10.3389/fonc.2015.00167", "ArticleIdList": ["10.3389/fonc.2015.00167", "PMC4517521", "26284193"]}, {"Citation": "Zhu L, Ren L, Chen Y, Fang J, Ge Z, Li X. Redox status of high-mobility group box 1 performs a dual role in angiogenesis of colorectal carcinoma. J Cell Mol Med. 2015;19(9):2128\u20132135. doi:10.1111/jcmm.12577", "ArticleIdList": ["10.1111/jcmm.12577", "PMC4568917", "26099505"]}, {"Citation": "Gorlach A, Dimova EY, Petry A, et al. Reactive oxygen species, nutrition, hypoxia and diseases: problems solved? Redox Biol. 2015;6:372\u2013385. doi:10.1016/j.redox.2015.08.016", "ArticleIdList": ["10.1016/j.redox.2015.08.016", "PMC4565025", "26339717"]}, {"Citation": "Gorlach A, Bertram K, Hudecova S, Krizanova O. Calcium and ROS: a mutual interplay. Redox Biol. 2015;6:260\u2013271. doi:10.1016/j.redox.2015.08.010", "ArticleIdList": ["10.1016/j.redox.2015.08.010", "PMC4556774", "26296072"]}, {"Citation": "Sun DK, Wang L, Zhang P. Antitumor effects of chrysanthemin in PC-3 human prostate cancer cells are mediated via apoptosis induction, caspase signalling pathway and loss of mitochondrial membrane potential. Afr J Tradit Complement Altern Med. 2017;14(4):54\u201361. doi:10.21010/ajtcam.v14i4.7", "ArticleIdList": ["10.21010/ajtcam.v14i4.7", "PMC5471482", "28638867"]}, {"Citation": "Wei C, Xiao Q, Kuang X, Zhang T, Yang Z, Wang L. Fucoidan inhibits proliferation of the SKM-1 acute myeloid leukaemia cell line via the activation of apoptotic pathways and production of reactive oxygen species. Mol Med Rep. 2015;12(5):6649\u20136655. doi:10.3892/mmr.2015.4252", "ArticleIdList": ["10.3892/mmr.2015.4252", "PMC4626197", "26324225"]}, {"Citation": "Seo KH, Ryu HW, Park MJ, et al. Mangosenone F, a furanoxanthone from Garciana mangostana, induces reactive oxygen species-mediated apoptosis in lung cancer cells and decreases xenograft tumor growth. Phytother Res. 2015;29(11):1753\u20131760. doi:10.1002/ptr.v29.11", "ArticleIdList": ["10.1002/ptr.v29.11", "26310849"]}, {"Citation": "Zhang WG, Liu XF, Meng KW, Hu SY. Puerarin inhibits growth and induces apoptosis in SMMC-7721 hepatocellular carcinoma cells. Mol Med Rep. 2014;10(5):2752\u20132758. doi:10.3892/mmr.2014.2512", "ArticleIdList": ["10.3892/mmr.2014.2512", "25175767"]}, {"Citation": "Wu CC, Bratton SB. Regulation of the intrinsic apoptosis pathway by reactive oxygen species. Antioxid Redox Signal. 2013;19(6):546\u2013558. doi:10.1089/ars.2012.4905", "ArticleIdList": ["10.1089/ars.2012.4905", "PMC3717204", "22978471"]}, {"Citation": "Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495\u2013516. doi:10.1080/01926230701320337", "ArticleIdList": ["10.1080/01926230701320337", "PMC2117903", "17562483"]}, {"Citation": "Ferreira CG, Epping M, Kruyt FA, Giaccone G. Apoptosis: target of cancer therapy. Clin Cancer Res. 2002;8(7):2024\u20132034.", "ArticleIdList": ["12114400"]}, {"Citation": "Ouyang L, Shi Z, Zhao S, et al. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2012;45(6):487\u2013498. doi:10.1111/cpr.2012.45.issue-6", "ArticleIdList": ["10.1111/cpr.2012.45.issue-6", "PMC6496669", "23030059"]}, {"Citation": "Yang Y, Zong M, Xu W, et al. Natural pyrethrins induces apoptosis in human hepatocyte cells via Bax- and Bcl-2-mediated mitochondrial pathway. Chem Biol Interact. 2017;262:38\u201345. doi:10.1016/j.cbi.2016.12.006", "ArticleIdList": ["10.1016/j.cbi.2016.12.006", "27939866"]}, {"Citation": "Plitzko B, Kaweesa EN, Loesgen S. The natural product mensacarcin induces mitochondrial toxicity and apoptosis in melanoma cells. J Biol Chem. 2017;292(51):21102\u201321116. doi:10.1074/jbc.M116.774836", "ArticleIdList": ["10.1074/jbc.M116.774836", "PMC5743083", "29074620"]}, {"Citation": "Yu Z, Li W. Induction of apoptosis by puerarin in colon cancer HT-29 cells. Cancer Lett. 2006;238(1):53\u201360. doi:10.1016/j.canlet.2005.06.022", "ArticleIdList": ["10.1016/j.canlet.2005.06.022", "16055262"]}, {"Citation": "Gan M, Yin X. Puerarin induced in mantle cell lymphoma apoptosis and its possible mechanisms involving multi-signaling pathway. Cell Biochem Biophys. 2015;71(1):367\u2013373. doi:10.1007/s12013-014-0207-y", "ArticleIdList": ["10.1007/s12013-014-0207-y", "25173778"]}, {"Citation": "Lin Y-J, Hou YC, Lin C-H, et al. Puerariae radix isoflavones and their metabolites inhibit growth and induce apoptosis in breast cancer cells. Biochem Biophys Res Commun. 2009;378(4):683\u2013688. doi:10.1016/j.bbrc.2008.10.178", "ArticleIdList": ["10.1016/j.bbrc.2008.10.178", "19013426"]}, {"Citation": "Chen T, Chen H, Wang Y, Zhang J. In vitro and in vivo antitumour activities of puerarin 6\u02b9\u02b9-O-xyloside on human lung carcinoma A549 cell line via the induction of the mitochondria-mediated apoptosis pathway. Pharm Biol. 2016;54(9):1793\u20131799. doi:10.3109/13880209.2015.1127980", "ArticleIdList": ["10.3109/13880209.2015.1127980", "26730946"]}, {"Citation": "Tang YH, Zhu HQ, Zhang YC, et al. Apoptosis of NB4 cells induced by flavonoids of puerarin in vitro. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010;18(2):326\u2013329.", "ArticleIdList": ["20416161"]}, {"Citation": "Hu Y, Li X, Lin L, Liang S, Yan J. Puerarin inhibits non-small cell lung cancer cell growth via the induction of apoptosis. Oncol Rep. 2018;39(4):1731\u20131738. doi:10.3892/or", "ArticleIdList": ["10.3892/or", "29393465"]}, {"Citation": "Yamamoto H, Ngan CY, Monden M. Cancer cells survive with survivin. Cancer Sci. 2008;99(9):1709\u20131714. doi:10.1111/j.1349-7006.2008.00870.x", "ArticleIdList": ["10.1111/j.1349-7006.2008.00870.x", "18537980"]}, {"Citation": "Li M, Song T, Yin ZF, Na YQ. XIAP as a prognostic marker of early recurrence of nonmuscular invasive bladder cancer. Chin Med J (Engl). 2007;120(6):469\u2013473. doi:10.1097/00029330-200703020-00007", "ArticleIdList": ["10.1097/00029330-200703020-00007", "17439739"]}, {"Citation": "Mizutani Y, Nakanishi H, Li YN, et al. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis. Int J Oncol. 2007;30(4):919\u2013925.", "ArticleIdList": ["17332931"]}, {"Citation": "Tamm I, Kornblau SM, Segall H, et al. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res. 2000;6(5):1796\u20131803.", "ArticleIdList": ["10815900"]}, {"Citation": "Foster FM, Owens TW, Tanianis-Hughes J, et al. Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer. Breast Cancer Res. 2009;11(3):R41. doi:10.1186/bcr2328", "ArticleIdList": ["10.1186/bcr2328", "PMC2716510", "19563669"]}, {"Citation": "Wang Y, Wu X, Zhou Y, Jiang H, Pan S, Sun B. Piperlongumine suppresses growth and sensitizes pancreatic tumors to gemcitabine in a xenograft mouse model by modulating the NF-kappa B pathway. Cancer Prev Res (Phila). 2016;9(3):234\u2013244. doi:10.1158/1940-6207.CAPR-15-0306", "ArticleIdList": ["10.1158/1940-6207.CAPR-15-0306", "26667450"]}, {"Citation": "Kong Y, Li F, Nian Y, et al. KHF16 is a leading structure from cimicifuga foetida that suppresses breast cancer partially by inhibiting the NF-kappaB signaling pathway. Theranostics. 2016;6(6):875\u2013886. doi:10.7150/thno.14694", "ArticleIdList": ["10.7150/thno.14694", "PMC4860895", "27162557"]}, {"Citation": "Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001;104(4):487\u2013501. doi:10.1016/S0092-8674(01)00237-9", "ArticleIdList": ["10.1016/S0092-8674(01)00237-9", "11239407"]}, {"Citation": "Ashkenazi A. Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev. 2008;19(3\u20134):325\u2013331. doi:10.1016/j.cytogfr.2008.04.001", "ArticleIdList": ["10.1016/j.cytogfr.2008.04.001", "18495520"]}, {"Citation": "Fulda S. Targeting extrinsic apoptosis in cancer: challenges and opportunities. Semin Cell Dev Biol. 2015;39:20\u201325. doi:10.1016/j.semcdb.2015.01.006", "ArticleIdList": ["10.1016/j.semcdb.2015.01.006", "25617598"]}, {"Citation": "Fatehchand K, Santhanam R, Shen B, et al. Active hexose-correlated compound enhances extrinsic-pathway-mediated apoptosis of acute myeloid leukemic cells. PLoS One. 2017;12(7):e0181729.", "ArticleIdList": ["PMC5519206", "28727820"]}, {"Citation": "Kang TH, Yoon G, Kang IA, Oh HN, Chae JI, Shim JH. Natural compound licochalcone B induced extrinsic and intrinsic apoptosis in human skin melanoma (A375) and squamous cell carcinoma (A431) cells. Phytother Res. 2017;31(12):1858\u20131867.", "ArticleIdList": ["29027311"]}, {"Citation": "Courtney KD, Corcoran RB, Engelman JA. The PI3K pathway as drug target in human cancer. J Clin Oncol. 2010;28(6):1075\u20131083. doi:10.1200/JCO.2009.25.3641", "ArticleIdList": ["10.1200/JCO.2009.25.3641", "PMC2834432", "20085938"]}, {"Citation": "Steelman LS, Chappell WH, Abrams SL, et al. Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy implications for cancer and aging. Aging (Albany NY). 2011;3(3):192\u2013222. doi:10.18632/aging.v3i3", "ArticleIdList": ["10.18632/aging.v3i3", "PMC3091517", "21422497"]}, {"Citation": "Wong KK, Engelman JA, Cantley LC. Targeting the PI3K signaling pathway in cancer. Curr Opin Genet Dev. 2010;20(1):87\u201390. doi:10.1016/j.gde.2009.11.002", "ArticleIdList": ["10.1016/j.gde.2009.11.002", "PMC2822054", "20006486"]}, {"Citation": "Samuels Y, Wang Z, Bardelli A, et al. High frequency of mutations of the PIK3CA gene in human cancers. Science. 2004;304(5670):554. doi:10.1126/science.1096502", "ArticleIdList": ["10.1126/science.1096502", "15016963"]}, {"Citation": "Samuels Y, Velculescu VE. Oncogenic mutations of PIK3CA in human cancers. Cell Cycle. 2004;3(10):1221\u20131224. doi:10.4161/cc.3.10.1164", "ArticleIdList": ["10.4161/cc.3.10.1164", "15467468"]}, {"Citation": "Kang S, Denley A, Vanhaesebroeck B, Vogt PK. Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase. Proc Natl Acad Sci U S A. 2006;103(5):1289\u20131294. doi:10.1073/pnas.0510772103", "ArticleIdList": ["10.1073/pnas.0510772103", "PMC1360601", "16432180"]}, {"Citation": "Vincent EE, Elder DJ, Thomas EC, et al. Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer. Br J Cancer. 2011;104(11):1755\u20131761. doi:10.1038/bjc.2011.132", "ArticleIdList": ["10.1038/bjc.2011.132", "PMC3111153", "21505451"]}, {"Citation": "Moselhy J, Srinivasan S, Ankem MK, Damodaran C. Natural products that target cancer stem cells. Anticancer Res. 2015;35(11):5773\u20135788.", "ArticleIdList": ["PMC7523548", "26503998"]}, {"Citation": "Jiang K, Chen H, Tang K, et al. Puerarin inhibits bladder cancer cell proliferation through the mTOR/p70S6K signaling pathway. Oncol Lett. 2018;15(1):167\u2013174. doi:10.3892/ol.2017.7298", "ArticleIdList": ["10.3892/ol.2017.7298", "PMC5766064", "29375709"]}, {"Citation": "Santarpia L, Lippman SM, El-Naggar AK. Targeting the MAPK-RAS-RAF signalling pathway in cancer therapy. Expert Opin Ther Targets. 2012;16(1):103\u2013119. doi:10.1517/14728222.2011.645805", "ArticleIdList": ["10.1517/14728222.2011.645805", "PMC3457779", "22239440"]}, {"Citation": "Chang F, Steelman LS, Lee JT, et al. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia. 2003;17(7):1263\u20131293.", "ArticleIdList": ["12835716"]}, {"Citation": "McCubrey JA, Steelman LS, Abrams SL, et al. Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy. Leukemia. 2008;22(4):708\u2013722. doi:10.1038/leu.2008.27", "ArticleIdList": ["10.1038/leu.2008.27", "18337766"]}, {"Citation": "Martelli AM, Evangelisti C, Chiarini F, et al. The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis. Biochim Biophys Acta. 2010;1803(9):991\u20131002. doi:10.1016/j.bbamcr.2010.04.005", "ArticleIdList": ["10.1016/j.bbamcr.2010.04.005", "20399811"]}, {"Citation": "Martelli AM, Evangelisti C, Chiarini F, McCubrey JA. The phosphatidylinositol 3- kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients. Oncotarget. 2010;1(2):89\u2013103. doi:10.18632/oncotarget.114", "ArticleIdList": ["10.18632/oncotarget.114", "PMC2911128", "20671809"]}, {"Citation": "Samatar AA, Poulikakos PI. Targeting RAS-ERK signalling in cancer: promises and challenges. Nat Rev Drug Discov. 2014;13(12):928\u2013942. doi:10.1038/nrd4281", "ArticleIdList": ["10.1038/nrd4281", "25435214"]}, {"Citation": "Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signalling pathways in cancer. Oncogene. 2007;26(22):3279\u20133290. doi:10.1038/sj.onc.1210421", "ArticleIdList": ["10.1038/sj.onc.1210421", "17496922"]}, {"Citation": "Kong AN, Yu R, Chen C, Mandlekar S, Primiano T. Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch Pharm Res. 2000;23(1):1\u201316. doi:10.1007/BF02976458", "ArticleIdList": ["10.1007/BF02976458", "10728649"]}, {"Citation": "Zhang WG, Yin XC, Liu XF, et al. Puerarin induces hepatocellular carcinoma cell apoptosis modulated by MAPK signaling pathways in a dose-dependent manner. Anticancer Res. 2017;37(8):4425\u20134431. doi:10.21873/anticanres.11837", "ArticleIdList": ["10.21873/anticanres.11837", "28739736"]}, {"Citation": "Kang H, Zhang J, Wang B, et al. Puerarin inhibits M2 polarization and metastasis of tumor-associated macrophages from NSCLC xenograft model via inactivating MEK/ERK 1/2 pathway. Int J Oncol. 2017;50(2):545\u2013554. doi:10.3892/ijo.2017.3841", "ArticleIdList": ["10.3892/ijo.2017.3841", "28101568"]}, {"Citation": "Hu Y, Liu K, Bo S, et al. Inhibitory effect of puerarin on vascular smooth muscle cells proliferation induced by oxidised low-density lipoprotein via suppressing ERK \u00bd phosphorylation and PCNA expression. Pharmazie. 2016;71(2):89\u201393.", "ArticleIdList": ["27004373"]}, {"Citation": "Kumar A, Singh UK, Kini SG, et al. JNK pathway signaling: a novel and smarter therapeutic targets for various biological diseases. Future Med Chem. 2015;7(15):2065\u20132086. doi:10.4155/fmc.15.132", "ArticleIdList": ["10.4155/fmc.15.132", "26505831"]}, {"Citation": "Kennedy NJ, Davis RJ. Role of JNK in tumor development. Cell Cycle. 2003;2(3):199\u2013201.", "ArticleIdList": ["12734425"]}, {"Citation": "Garcia-Barrado MJ, Blanco EJ, Iglesias-Osma MC. Relation among aromatase P450 and tumoral growth in human prolactinomas. Int J Mol Sci. 2017;18(11):2299.", "ArticleIdList": ["PMC5713269", "29104246"]}, {"Citation": "Yan L, Liu X, Yin A, Wei Y, Yang Q, Kong B. Huaier aqueous extract inhibits cervical cancer cell proliferation via JNK/p38 pathway. Int J Oncol. 2015;47(3):1054\u20131060. doi:10.3892/ijo.2015.3094", "ArticleIdList": ["10.3892/ijo.2015.3094", "26201539"]}, {"Citation": "Li X, Lao Y, Zhang H, et al. The natural compound guttiferone F sensitizes prostate cancer to starvation induced apoptosis via calcium and JNK elevation. BMC Cancer. 2015;15:254. doi:10.1186/s12885-015-1292-z", "ArticleIdList": ["10.1186/s12885-015-1292-z", "PMC4394563", "25885018"]}, {"Citation": "Zhai T, Hei Z, Ma Q, et al. Shikonin induces apoptosis and G0/G1 phase arrest of gallbladder cancer cells via the JNK signaling pathway. Oncol Rep. 2017;38(6):3473\u20133480. doi:10.3892/or.2017.6038", "ArticleIdList": ["10.3892/or.2017.6038", "29039581"]}, {"Citation": "Yu C, Li Y, Chen H, Yang S, Xie G. Decreased expression of aromatase in the Ishikawa and RL95-2 cells by the isoflavone, puerarin, is associated with inhibition of c-jun expression and AP-1 activity. Food Chem Toxicol. 2008;46(12):3671\u20133676. doi:10.1016/j.fct.2008.09.045", "ArticleIdList": ["10.1016/j.fct.2008.09.045", "18848966"]}, {"Citation": "Khan M, Rasul A, Yi F, Zhong L, Ma T. Jaceosidin induces p53-dependent G2/M phase arrest in U87 glioblastoma cells. Asian Pac J Cancer Prev. 2011;12(12):3235\u20133238.", "ArticleIdList": ["22471459"]}, {"Citation": "Lu MC, Yang SH, Hwang SL, et al. Induction of G2/M phase arrest by squamocin in chronic myeloid leukemia (K562) cells. Life Sci. 2006;78(20):2378\u20132383. doi:10.1016/j.lfs.2005.09.048", "ArticleIdList": ["10.1016/j.lfs.2005.09.048", "16310807"]}, {"Citation": "Yang G, Chang B, Yang F, et al. Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. Clin Cancer Res. 2010;16(12):3171\u20133181. doi:10.1158/1078-0432.CCR-09-3171", "ArticleIdList": ["10.1158/1078-0432.CCR-09-3171", "PMC2930838", "20423983"]}, {"Citation": "Horn HF, Vousden KH. Coping with stress: multiple ways to activate p53. Oncogene. 2007;26(9):1306\u20131316. doi:10.1038/sj.onc.1210263", "ArticleIdList": ["10.1038/sj.onc.1210263", "17322916"]}, {"Citation": "Bourougaa K, Naski N, Boularan C, et al. Endoplasmic reticulum stress induces G2 cell-cycle arrest via mRNA translation of the p53 isoform p53/47. Mol Cell. 2010;38(1):78\u201388. doi:10.1016/j.molcel.2010.01.041", "ArticleIdList": ["10.1016/j.molcel.2010.01.041", "20385091"]}, {"Citation": "Newman DJ, Cragg GM, Holbeck S, Sausville EA. Natural products and derivatives as leads to cell cycle pathway targets in cancer chemotherapy. Curr Cancer Drug Targets. 2002;2(4):279\u2013308. doi:10.2174/1568009023333791", "ArticleIdList": ["10.2174/1568009023333791", "12470208"]}, {"Citation": "Shao HM, Tang YH, Jiang PJ, et al. Inhibitory effect of flavonoids of puerarin on proliferation of different human acute myeloid leukemia cell lines in vitro. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010;18(2):296\u2013299.", "ArticleIdList": ["20416155"]}, {"Citation": "Peng XY, Qi ZH, Chen HP. Study on the differentiation and apoptosis of HL-60 cell line induced by Puerarin. Hunan Yi Ke Da Xue Xue Bao. 2001;26(2):126\u2013128.", "ArticleIdList": ["12536642"]}, {"Citation": "Carling D, Clarke PR, Zammit VA, Hardie DG. Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3- hydroxy-3-methylglutaryl-CoA reductase kinase activities. Eur J Biochem. 1989;186(1\u20132):129\u2013136. doi:10.1111/ejb.1989.186.issue-1-2", "ArticleIdList": ["10.1111/ejb.1989.186.issue-1-2", "2598924"]}, {"Citation": "Horike N, Sakoda H, Kushiyama A, et al. AMP-activated protein kinase activation increases phosphorylation of glycogen synthase kinase 3beta and thereby reduces cAMP-responsive element transcriptional activity and phosphoenolpyruvate carboxykinase C gene expression in the liver. J Biol Chem. 2008;283(49):33902\u201333910. doi:10.1074/jbc.M802537200", "ArticleIdList": ["10.1074/jbc.M802537200", "PMC2662216", "18801732"]}, {"Citation": "Fiol CJ, Williams JS, Chou CH, Wang QM, Roach PJ, Andrisani OM. A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression. J Biol Chem. 1994;269(51):32187\u201332193.", "ArticleIdList": ["7798217"]}, {"Citation": "Lim JC, Kania KD, Wijesuriya H, et al. Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells. J Neurochem. 2008;106(4):1855\u20131865. doi:10.1111/j.1471-4159.2008.05537.x", "ArticleIdList": ["10.1111/j.1471-4159.2008.05537.x", "PMC4303914", "18624906"]}, {"Citation": "Krishna R, Mayer LD. Multidrug resistance (MDR) in cancer: mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci. 2000;11(4):265\u2013283.", "ArticleIdList": ["11033070"]}, {"Citation": "Takano M, Kakizoe S, Kawami M, et al. Modulation of P-glycoprotein function and multidrug resistance in cancer cells by Thai plant extracts. Pharmazie. 2014;69(11):823\u2013828.", "ArticleIdList": ["25985578"]}, {"Citation": "Sreenivasan S, Ravichandran S, Vetrivel U, Krishnakumar S. Modulation of multidrug resistance 1 expression and function in retinoblastoma cells by curcumin. J Pharmacol Pharmacother. 2013;4(2):103\u2013109. doi:10.4103/0976-500X.110882", "ArticleIdList": ["10.4103/0976-500X.110882", "PMC3669568", "23761708"]}, {"Citation": "Hien TT, Kim HG, Han EH, Kang KW, Jeong HG. Molecular mechanism of suppression of MDR1 by puerarin from pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP activated protein kinase in breast cancer MCF-7/adr cells. Mol Nutr Food Res. 2010;54(7):918\u2013928. doi:10.1002/mnfr.200900146", "ArticleIdList": ["10.1002/mnfr.200900146", "20077420"]}, {"Citation": "Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986;46(5):705\u2013716. doi:10.1016/0092-8674(86)90346-6", "ArticleIdList": ["10.1016/0092-8674(86)90346-6", "3091258"]}, {"Citation": "Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007;8(1):49\u201362. doi:10.1038/nrm2083", "ArticleIdList": ["10.1038/nrm2083", "17183360"]}, {"Citation": "Arkan MC, Greten FR. IKK- and NF-kappaB-mediated functions in carcinogenesis. Curr Top Microbiol Immunol. 2011;349:159\u2013169. doi:10.1007/82_2010_97", "ArticleIdList": ["10.1007/82_2010_97", "20845109"]}, {"Citation": "Basseres DS, Baldwin AS. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene. 2006;25(51):6817\u20136830. doi:10.1038/sj.onc.1209942", "ArticleIdList": ["10.1038/sj.onc.1209942", "17072330"]}, {"Citation": "Prasad S, Ravindran J, Aggarwal BB. NF-kappaB and cancer: how intimate is this relationship. Mol Cell Biochem. 2010;336(1\u20132):25\u201337. doi:10.1007/s11010-009-0267-2", "ArticleIdList": ["10.1007/s11010-009-0267-2", "PMC3148942", "19823771"]}, {"Citation": "Park JH, Jeong YJ, Won HK, Choi SY, Park JH, Oh SM. Activation of TOPK by lipopolysaccharide promotes induction of inducible nitric oxide synthase through NFkappaB activity in leukemia cells. Cell Signal. 2014;26(5):849\u2013856. doi:10.1016/j.cellsig.2014.01.004", "ArticleIdList": ["10.1016/j.cellsig.2014.01.004", "24440499"]}, {"Citation": "Yamamoto K, Arakawa T, Ueda N, Yamamoto S. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem. 1995;270(52):31315\u201331320. doi:10.1074/jbc.270.52.31315", "ArticleIdList": ["10.1074/jbc.270.52.31315", "8537402"]}, {"Citation": "M\u00fcller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50. doi:10.1038/35065016", "ArticleIdList": ["10.1038/35065016", "11242036"]}, {"Citation": "Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol. 2016;12(1):49\u201362. doi:10.1038/nrrheum.2015.169", "ArticleIdList": ["10.1038/nrrheum.2015.169", "PMC4809675", "26656660"]}, {"Citation": "Brenner D, Blaser H, Mak TW. Regulation of tumour necrosis factor signalling: live or let die. Nat Rev Immunol. 2015;15(6):362\u2013374. doi:10.1038/nri3834", "ArticleIdList": ["10.1038/nri3834", "26008591"]}, {"Citation": "Ali A, Kim SH, Kim MJ, et al. O-GlcNAcylation of NF-kappaB promotes lung metastasis of cervical cancer cells via upregulation of CXCR4 expression. Mol Cells. 2017;40(7):476\u2013484. doi:10.14348/molcells.2017.2309", "ArticleIdList": ["10.14348/molcells.2017.2309", "PMC5547217", "28681591"]}, {"Citation": "Hopken UE, Foss HD, Meyer D, et al. Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs. Blood. 2002;99(4):1109\u20131116. doi:10.1182/blood.V99.4.1109", "ArticleIdList": ["10.1182/blood.V99.4.1109", "11830455"]}, {"Citation": "Nabekura T, Hiroi T, Kawasaki T, Uwai Y. Effects of natural nuclear factor-kappa B inhibitors on anticancer drug efflux transporter human P-glycoprotein. Biomed Pharmacother. 2015;70:140\u2013145. doi:10.1016/j.biopha.2015.01.007", "ArticleIdList": ["10.1016/j.biopha.2015.01.007", "25776492"]}, {"Citation": "Liu X, Zhao W, Wang W, Lin S, Yang L. Puerarin suppresses LPS-induced breast cancer cell migration, invasion and adhesion by blockage NF-kappaB and Erk pathway. Biomed Pharmacother. 2017;92:429\u2013436. doi:10.1016/j.biopha.2017.05.102", "ArticleIdList": ["10.1016/j.biopha.2017.05.102", "28558356"]}, {"Citation": "Liu X, Li S, Li Y, Cheng B, Tan B, Wang G. Puerarin inhibits proliferation and induces apoptosis by upregulation of miR-16 in bladder cancer cell line T24. Oncol Res. 2018;26(8):1227\u20131234. doi:10.3727/096504018X15178736525106", "ArticleIdList": ["10.3727/096504018X15178736525106", "PMC7844627", "29422113"]}, {"Citation": "Zhang H, Zhai Z, Zhou H, et al. Puerarin inhibits oxLDL-induced macrophage activation and foam cell formation in human THP1 macrophage. Biomed Res Int. 2015;2015:403616. doi:10.1155/2015/403616", "ArticleIdList": ["10.1155/2015/403616", "PMC4631854", "26576421"]}, {"Citation": "Singh N, Baby D, Rajguru JP, Patil PB, Thakkannavar SS, Pujari VB. Inflammation and cancer. Ann Afr Med. 2019;18(3):121\u2013126. doi:10.4103/aam.aam_56_18", "ArticleIdList": ["10.4103/aam.aam_56_18", "PMC6704802", "31417011"]}, {"Citation": "Na YR, Je S, Seok SH. Metabolic features of macrophages in inflammatory diseases and cancer. Cancer Lett. 2018;413:46\u201358. doi:10.1016/j.canlet.2017.10.044", "ArticleIdList": ["10.1016/j.canlet.2017.10.044", "29100962"]}, {"Citation": "Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 2005;7(3):211\u2013217. doi:10.1016/j.ccr.2005.02.013", "ArticleIdList": ["10.1016/j.ccr.2005.02.013", "15766659"]}, {"Citation": "Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell. 2004;6(5):447\u2013458. doi:10.1016/j.ccr.2004.09.028", "ArticleIdList": ["10.1016/j.ccr.2004.09.028", "15542429"]}, {"Citation": "DiDonato JA, Mercurio F, Karin M. NF-kappaB and the link between inflammation and cancer. Immunol Rev. 2012;246(1):379\u2013400. doi:10.1111/j.1600-065X.2012.01099.x", "ArticleIdList": ["10.1111/j.1600-065X.2012.01099.x", "22435567"]}, {"Citation": "Qin J, Wang W, Zhang R. Novel natural product therapeutics targeting both inflammation and cancer. Chin J Nat Med. 2017;15(6):401\u2013416. doi:10.1016/S1875-5364(17)30062-6", "ArticleIdList": ["10.1016/S1875-5364(17)30062-6", "PMC6663108", "28629530"]}, {"Citation": "Liu L, Liao JZ, He XX, Li PY. The role of autophagy in hepatocellular carcinoma: friend or foe. Oncotarget. 2017;8(34):57707\u201357722. doi:10.18632/oncotarget.17202", "ArticleIdList": ["10.18632/oncotarget.17202", "PMC5593678", "28915706"]}, {"Citation": "Arakawa S, Honda S, Yamaguchi H, Shimizu S. Molecular mechanisms and physiological roles of Atg5/Atg7-independent alternative autophagy. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(6):378\u2013385. doi:10.2183/pjab.93.023", "ArticleIdList": ["10.2183/pjab.93.023", "PMC5709538", "28603209"]}, {"Citation": "Wang P, Zhu L, Sun D, et al. Natural products as modulator of autophagy with potential clinical prospects. Apoptosis. 2017;22(3):325\u2013356. doi:10.1007/s10495-016-1335-1", "ArticleIdList": ["10.1007/s10495-016-1335-1", "27988811"]}], "ReferenceList": []}], "History": [{"Year": "2019", "Month": "10", "Day": "5"}, {"Year": "2019", "Month": "12", "Day": "16"}, {"Year": "2020", "Month": "2", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "6", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "1", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["32021425", "PMC6956866", "10.2147/CMAR.S233567", "233567"]}}], "PubmedBookArticle": []}